Showing 631-640 of 23030 results for "".
Advancing Care: Clinical Innovations on the Horizon
https://mededonthego.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.CKD-aP Treatment Tool Kit
https://reachmd.com/programs/cme/ckd-ap-treatment-tool-kit/36297/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.CKD-aP: Beyond the Surface
https://reachmd.com/programs/cme/ckd-ap-beyond-the-surface/36294/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.The Patient-Clinician Connection in Managing CKD-aP
https://reachmd.com/programs/cme/the-patient-clinician-connection-in-managing-ckd-ap/36302/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
https://reachmd.com/programs/cme/targeting-b7-h3-in-es-sclc-advancing-targeted-therapy-through-evidence-based-innovation-and-multidisciplinary-care/36232/Explore the rationale and emerging efficacy and safety data for B7-H3–targeted ADCs in ES-SCLC to support patient selection and multidisciplinary care.Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
https://reachmd.com/programs/cme/optimize-outcomes-in-ckd-t2d-a-practical-approach-to-initiating-and-monitoring-combination-ns-mra-sglt2i-therapy/29904/Time is nephron mass! Learn how nephrologists apply CONFIDENCE data & 4-pillar therapy to transform CKD + T2D care in this real-world case.Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
https://reachmd.com/programs/cme/parallels-between-kidney-transplantation-and-maternal-anti-fetal-rejection/13911/Get below the surface and explore what kidney transplantation & maternal anti-fetal rejection have in common. The answer could change your practice.Are You On Top of Pediatric Atopic Dermatitis? Expert Guidance for Leveraging the Latest Advances in Systemic Therapy
https://reachmd.com/programs/cme/are-you-on-top-of-pediatric-atopic-dermatitis-expert-guidance-for-leveraging-the-latest-advances-in-systemic-therapy/54260/On-demand webcast of expert faculty presentation on the disease burden of pediatric atopic dermatitis and strategies for helping patients achieve disease control with systemic therapy.Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
https://reachmd.com/programs/cme/understanding-igan-fsgs-pathophysiology-and-emerging-therapies/14974/Hear experts discuss how emerging therapies for IgAN and FSGS may achieve proteinuria remission and shape clinical treatment decisions for patients.Kaiser's Cure for Improving Care: Get Integrated
https://reachmd.com/programs/clinicians-roundtable/kaisers-cure-for-improving-care-get-integrated/2793/When it comes to an integrated health care system, Kaiser Permanente has been at the forefront. Dr. Robert Pearl, executive director and CEO of the Permanente Medical Group, tells the Chicago Tribune's Bruce Japsen how integration among doctors and health care facilities——coordinating care at all le